Targeting Tumor Regulators in Pediatric High-Risk Neural Tumors (PHRNT), A Novel Small Molecule Approach to MYC-N Amplified Pediatric Cancers
Time: 4:40 pm
day: Day One Mid Day
Details:
- Novel small molecule therapy targeting tumor regulators in pediatric high-risk neural tumors (PHRNT), focusing on MYC-N amplified cancers.
- Cutting-edge approach that disrupts oncogenic pathways and restores protein homeostasis, offering a breakthrough treatment for pediatric cancers.
- Addressing a critical unmet need in pediatric oncology with the potential to reshape treatment paradigms and significantly improve survival rates